Asthma clinical remission among patients taking dupilumab is most likely to occur in those with increased baseline BEC and FeNO levels.

Adding paridiprubart to standard care in ICU patients with COVID respiratory distress may reduce invasive support needs and allow earlier discharge.

Prior COVID-19 infection was not independently associated with an increased risk for upper respiratory tract infections in adults.

Among ICU patients with cirrhosis and sepsis, a high lactate-to-hematocrit ratio predicted short- and long-term mortality.

Tirzepatide treatment may lead to OSA remission or mild nonsymptomatic OSA in patients with moderate to severe OSA and obesity.

Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.

CHEST 2025, the 90th annual meeting of the American College of Chest Physicians, opens on "Love Your Lungs Day" on October 19 in Chicago.

CHIP at a VAF of 10% or greater is the strongest predictor of whether daily low-dose aspirin can help prevent cancer in healthy, older adults.

The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.

Smoking among individuals with cirrhosis exacerbates inflammation, fibrogenesis, and angiogenesis, and increases risk for extrahepatic cancers in ACLD.

Investigators assessed markers of chronic kidney disease (CKD) with cancer risks using data from more than one million patients.